Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pete Humphries

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Human Molecular Genetics|May 17, 2017
Toward an elucidation of the molecular genetics of inherited retinal degenerationsG Jane Farrar, Matthew Carrigan, Adrian Dockery, et al.
International Journal of Molecular Sciences|February 25, 2023
RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD ModelsSophia Millington-Ward, Naomi Chadderton, Laura K Finnegan, et al.
Human Molecular Genetics|March 5, 2002
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) miceAvril Kennan, Aileen Aherne, Arpad Palfi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2005
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approachAnna-Sophia Kiang, Arpad Palfi, Marius Ader, et al.
Molecular Therapy. Methods & Clinical Development|December 30, 2020
siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent modelPaul S Cassidy, Ruth A Kelly, Ester Reina-Torres, et al.
Human Molecular Genetics|April 4, 2008
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10)Lawrence C S Tam, Anna-Sophia Kiang, Avril Kennan, et al.
Human Molecular Genetics|February 26, 2004
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosaAileen Aherne, Avril Kennan, Paul F Kenna, et al.
American Journal of Human Genetics|June 15, 2007
RNA interference-mediated suppression and replacement of human rhodopsin in vivoMary O'Reilly, Arpad Palfi, Naomi Chadderton, et al.
JCI Insight|August 9, 2019
Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophyNatalie Hudson, Lucia Celkova, Alan Hopkins, et al.
Scientific Reports|January 17, 2017
Enhancement of Outflow Facility in the Murine Eye by Targeting Selected Tight-Junctions of Schlemm's Canal EndotheliaLawrence C S Tam, Ester Reina-Torres, Joseph M Sherwood, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Human Molecular Genetics|May 17, 2017
Toward an elucidation of the molecular genetics of inherited retinal degenerationsG Jane Farrar, Matthew Carrigan, Adrian Dockery, et al.
International Journal of Molecular Sciences|February 25, 2023
RPE-Directed Gene Therapy Improves Mitochondrial Function in Murine Dry AMD ModelsSophia Millington-Ward, Naomi Chadderton, Laura K Finnegan, et al.
Human Molecular Genetics|March 5, 2002
Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) miceAvril Kennan, Aileen Aherne, Arpad Palfi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 22, 2005
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approachAnna-Sophia Kiang, Arpad Palfi, Marius Ader, et al.
Molecular Therapy. Methods & Clinical Development|December 30, 2020
siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent modelPaul S Cassidy, Ruth A Kelly, Ester Reina-Torres, et al.
Human Molecular Genetics|April 4, 2008
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10)Lawrence C S Tam, Anna-Sophia Kiang, Avril Kennan, et al.
Human Molecular Genetics|February 26, 2004
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosaAileen Aherne, Avril Kennan, Paul F Kenna, et al.
American Journal of Human Genetics|June 15, 2007
RNA interference-mediated suppression and replacement of human rhodopsin in vivoMary O'Reilly, Arpad Palfi, Naomi Chadderton, et al.
JCI Insight|August 9, 2019
Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophyNatalie Hudson, Lucia Celkova, Alan Hopkins, et al.
Scientific Reports|January 17, 2017
Enhancement of Outflow Facility in the Murine Eye by Targeting Selected Tight-Junctions of Schlemm's Canal EndotheliaLawrence C S Tam, Ester Reina-Torres, Joseph M Sherwood, et al.
Pageof 3